MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) had an impressive performance on Wednesday, seeing a 12% increase during regular trading hours. However, the real excitement began in the afterhours session, where the stock skyrocketed by an additional 87%, nearly doubling its price by the end of the day. This surge was driven by the announcement of […]
MingZhu Logistics’ Stock Soars 87% on High-Profile Contract Win Read More »
In recent trading sessions, UniQure (NASDAQ: QURE) shares have soared by 56.15% to $10.41, bolstered by optimistic interim findings from ongoing clinical trials. The data highlights a notable slowdown in disease progression and reduced neurofilament light chain (NfL) levels, crucial markers in Huntington’s disease. Long-term Therapeutic Potential and Regulatory Pathway Advancements UniQure explores a unique
uniQure (QURE) Shares Soar On Positive Medical Trial News Read More »
Solaris Oilfield Infrastructure, Inc. (NYSE: SOI) is experiencing a significant uptick in its stock value today, spurred by a strategic acquisition move in the energy sector. As of the last check during the current-market session, SOI’s stock soared 35.05% to $11.16. Acquisition of Mobile Energy Rentals LLC Solaris (SOI) has formally announced its agreement to
Solaris (SOI) Drives Growth With Strategic Acquisition, Stock Rises Read More »
Announcing positive results from a pilot study, shares of Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) have nearly doubled in value on the US stock charts today. As of the latest market assessment, VRPX stock has surged by 99.04%, reaching $2.30. Promising Study Results for Probudur Virpax Pharmaceuticals disclosed the results of a Swine Model pilot study
Virpax Pharmaceuticals (VRPX) Stock Rises On Promising Study Results Read More »
After securing pivotal regulatory approval, Longeveron Inc. (NASDAQ: LGVN) stock is witnessing a substantial uptick in the current market session. As of the latest assessment, LGVN shares have surged by 53.11% on the US stock charts, reaching $4.39. Lomecel-B Receives RMAT Designation from the FDA A news statement from Longeveron (LGVN) states that the Regenerative
Longeveron (LGVN) Experiences Stock Boost Following Regulatory Green Light Read More »
Shares of VivoPower International PLC (NASDAQ: VVPR) have seen a significant increase on the US stock charts today, driven by an announcement regarding an equity move. As of the most recent current-market check, VVPR stock surged by 50.79%, reaching $3.84. Amendment and Extension of Shareholder Loan Financing Agreement Today, VivoPower International announced that its independent
Equity Move Sparks Significant Rise In VivoPower (VVPR) Stock Read More »
Treasure Global Inc. (NASDAQ: TGL) experienced a significant rebound on the US stock charts on Monday, following a strategic acquisition move. Despite a 5.36% decline during regular trading hours, TGL shares fully recovered after-hours, climbing 5.66% to close at $2.80. Strategic Acquisition by Treasure Global Treasure Global declared its intention to buy all of the
Acquisition Move Propels Treasure Global (TGL) To Stock Recovery Read More »
Shares of Nexgel, Inc. (NASDAQ: NXGL) experienced a notable recovery on the US stock charts following the market close on Monday, driven by record revenue figures. During the after-market session, NXGL stock surged by 17.16% to reach $2.39, recovering from a regular-session loss of -7.69%. Quarterly Revenue of Nexgel Nexgel announced its preliminary, unaudited revenue
Nexgel (NXGL) Sees Recovery On US Stock Charts Following Record Quarterly Revenue Read More »
Shares of Beam Global (NASDAQ: BEEM) exhibited a notable surge during the extended trading session on Monday, following the company’s announcement of unprecedented quarterly orders and its inaugural European order. The stock closed the regular session with an 18.00% increase, reaching $6.49, and continued to rise on US stock charts by 15.41% in the extended
Extended Session Rally For Beam Global (BEEM) After Record-Breaking Orders Read More »
Morphic Holding, Inc. (NASDAQ: MORF) saw a remarkable surge in premarket trading, jumping 76% to $56.15 per share following Eli Lilly’s announcement of its acquisition of the biopharmaceutical company for $3.2 billion in cash. This acquisition underscores Lilly’s strategic move to expand its portfolio in integrin therapeutics, specifically targeting inflammatory bowel diseases (IBD). Morphic Overview
Morphic Holding Surges 76% on Eli Lilly Acquisition Deal Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.